News
-
-
-
-
-
-
-
-
PRESS RELEASE
Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Onco-Innovations partners with Dalton Pharma Services to synthesize heavy labelled PNKP inhibitor for increasing survival rate in colorectal cancer mice. Study showcases promising therapeutic potential -
-